cbdMD, Inc. (YCBD) Q1 2026 Earnings Call Transcript

Thank you, Jim, and thank you all for joining cbdMD's December 31, 2025, First Quarter of Fiscal 2026 Earnings Call and Update. On the call today, we also have Ronan Kennedy, our Chief Executive ...
California Lutheran University

AMA Waterways launches internship program at the SOM!

At Cal Lutheran, you'll find a dedicated and open-minded community of scholars.
Le Lézard

FDA approves RYBREVANT FASPROtm (amivantamab and hyaluronidase-lpuj) as the only EGFR-targeted therapy that can be administered once a month

Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved a new, simplified monthly dosing schedule* for RYBREVANT FASPROtm (amivantamab and hyaluronidase-lpuj). When ...
Le Lézard

Juvenile Idiopathic Arthritis Market is Expected to Expand at a Healthy Growth Rate of 5.6% During the Forecast Period (2026-2036) | DelveInsight

Recently published Juvenile Idiopathic Arthritis Market Insights report includes a comprehensive understanding of current treatment practices, juvenile idiopathic arthritis emerging drugs, market ...

Sims Limited (SMSMY) Q2 2026 Earnings Call Transcript

Q2 2026 Earnings Call February 16, 2026 6:01 PM ESTCompany ParticipantsStephen Mikkelsen - Group CEO, Director & MDWarrick R.

Johnson & Johnson: FDA approves RYBREVANT FASPRO (amivantamab and hyaluronidase-lpuj) as the only EGFR-targeted therapy that can be administered once a month

Monthly dosing reduces treatment visits while maintaining established safety and efficacy1,2 Builds on RYBREVANT FASPRO FDA approval to deliver the simplest and fastest ...
Winston-Salem Journal

Undetected poaching crimes come with $1.4 billion price tag to US. taxpayers, study shows

"Poachers are stealing from hunters, but they are stealing from all of us, whether you hunt or not, because wildlife belongs ...